Group 1 - The Hong Kong Innovative Drug 50 ETF (513780) increased by 4.15% on July 29, with a trading volume of 985 million yuan [1] - The fund's shares rose by 80.5 million, bringing the total shares to 844 million, with an increase of 87.5 million shares over the last 20 trading days [1] - The latest net asset value of the fund is calculated at 1.606 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug 50 ETF is the CSI Hong Kong Stock Connect Innovative Drug Index return rate, adjusted for valuation exchange rates [1] - The fund is managed by Invesco Great Wall Fund Management Co., with fund managers Jin Huang and Zhang Xiaonan [1] - Since its establishment on October 16, 2024, the fund has achieved a return of 90.41%, with a one-month return of 32.21% [1]
7月29日港股创新药50ETF（513780）份额增加8050.00万份，最新份额8.44亿份，最新规模16.06亿元
Xin Lang Cai Jing·2025-07-30 01:11